MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Bioadvance.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Bioadvance.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Bioadvance.com most likely does not offer any adult content.
Audience
-
Time on site
08:15
AVG
-
Gender
Men
N/A
Women
N/A
Popular pages
-
BioAdvance
Venatorx Pharmaceuticals Announces FDA Acceptance and Priority Review of New Drug Application for Cefepime-Taniborbactam to Treat Complicated Urinary Tract Infections (cUTI), including Pyelonephritis,...
-
About - BioAdvance Capital
BioAdvance is an evergreen fund established to address the critical needs of emerging human life science focused companies.
-
Archives for 2021 | BioAdvance
Renovacor Announces Third Quarter 2021 Financial Results and Provides Corporate Update Debuted as a public company and strengthened liquidity position with $95.1 million in gross proceeds from the bus...
- BioAdvance News | BioAdvance
-
Team | BioAdvance
BioAdvance’s seasoned team has deep industry experience including business executives, scientists, physicians, entrepreneurs and venture capitalists.
- Posts by bioadvance | BioAdvance